LAZARD ASSET MANAGEMENT LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,461
-26.8%
60,790
-2.7%
0.00%0.0%
Q2 2023$1,995
+4.3%
62,490
-0.0%
0.00%
-33.3%
Q1 2023$1,913
-20.7%
62,505
+1.3%
0.00%0.0%
Q4 2022$2,412
-100.0%
61,689
-45.8%
0.00%
-62.5%
Q3 2022$5,423,000
+29.7%
113,852
+5.4%
0.01%
+33.3%
Q2 2022$4,181,000
+3.0%
108,032
+52.5%
0.01%
+20.0%
Q1 2022$4,059,000
-4.1%
70,850
+33.4%
0.01%0.0%
Q4 2021$4,233,000
+88.6%
53,128
+105.9%
0.01%
+66.7%
Q3 2021$2,245,000
-29.1%
25,806
+4.9%
0.00%
-25.0%
Q2 2021$3,165,000
+10450.0%
24,591
+6354.3%
0.00%
Q1 2021$30,0003810.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders